bauplan | $7,500,000 | (Apr 17, 2025)
Finch(US) | Undisclosed Amount | (Apr 17, 2025)
Glycomine Inc. | $115,000,000 | (Apr 17, 2025)
Certified by Founder
Lodge
DotBio
start up
Singapore
- Singapore
- 07/08/2023
- Pre Series A
- $5,600,000
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com
- Industry Biotechnology Research
- Website https://www.dotbio.com/
- LinkedIn https://www.linkedin.com/company/dotbio/about/
Atomic(US1) | $3,000,000 | (Apr 17, 2025)
Skin Analytics | $19,833,225 | (Apr 17, 2025)
PeopleForce | $5,400,000 | (Apr 17, 2025)
telli (YC F24) | $3,600,000 | (Apr 17, 2025)
Blue Onion | $10,000,000 | (Apr 17, 2025)
Inephany | $2,200,000 | (Apr 17, 2025)
Luma Financial Technologies | $63,000,000 | (Apr 17, 2025)
Scout AI | $15,000,000 | (Apr 17, 2025)
Tundr | $8,187,552 | (Apr 17, 2025)